QuantRx Biomedical Corporation
QTXB
$0.0005
$0.0003150.00%
| 09/30/2022 | 06/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -72.86% | 647.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -72.86% | 647.22% | |||
| Operating Income | 72.86% | -647.22% | |||
| Income Before Tax | 24.26% | -40.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 24.26% | -40.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.26% | -40.52% | |||
| EBIT | 72.86% | -647.22% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 20.00% | -42.86% | |||
| Normalized Basic EPS | 16.67% | -20.00% | |||
| EPS Diluted | 20.00% | -42.86% | |||
| Normalized Diluted EPS | 16.67% | -20.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
